Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Women's Health Science Journal Research Article 1 min read

Melatonin Should be Urgently Considered as a Cheap and Efficient COVID-19 Therapeutic

Tesarik J*
* Corresponding author
ISSN: 2639-2526  10.23880/whsj-16000160  Received: July 21, 2021  Published: August 09, 2021
 — views
 3 references
PDF
Abstract

In a recent article [1] the authors highlight the urgent needs to develop efficient COVID-19 therapeutics to be rapidly applied in low-middle-income countries to forestall the collapse of overburdened health systems in resourselimited settings. Among other agents, the paper mentions anti-inflammatory and immunomodulatory agents, but only as part of later-stage interventions aimed at preventing downstream consequences [1].

References

  1. Batista C, Shoham S, Ergonul O, Hotez P, Bottazzi ME, et al. (2021) Urgent needs to accelerate the race for COVID-19 therapeutics. EClinicalMedicine 36: 100911.
  2. Tesarik J (2020) Melatonin to reduce death toll due to COVID-19. From innate to adaptive immune response. Glob J Med Res K: Interdisciplinary 20(8).
  3. Tesarik J, Reiter RJ. Melatonin as an adjuvant in COVID-19 vaccinacion. J SARS-CoV-2 Coronavirus Disease. COVID 2: 009.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{tesarik2021,
  title   = {Melatonin Should be Urgently Considered as a Cheap and Efficient COVID-19 Therapeutic},
  author  = {Tesarik J},
  journal = {Women\'s Health Science Journal},
  year    = {2021},
  volume  = {5},
  number  = {2},
  doi     = {10.23880/whsj-16000160}
}
Tesarik J (2021). Melatonin Should be Urgently Considered as a Cheap and Efficient COVID-19 Therapeutic. Women's Health Science Journal, 5(2). https://doi.org/10.23880/whsj-16000160
TY  - JOUR
TI  - Melatonin Should be Urgently Considered as a Cheap and Efficient COVID-19 Therapeutic
AU  - Tesarik J
JO  - Women's Health Science Journal
PY  - 2021
VL  - 5
IS  - 2
DO  - 10.23880/whsj-16000160
ER  -